Table 2 Clinical indications of 3 anthroposophic medicine modalities prescribed for quality of life (QOL) improvement
From: Barriers and challenges in integration of anthroposophic medicine in supportive breast cancer care
AM modality | Number of AM users | Common QOL-oriented clinical indications (including specific supplements indicated) | Patient compliance |
|---|---|---|---|
n (%) | n (%) | ||
Mistletoe injections | 23 (41.1) | Fatigue | 12 (52.2)* |
Leukopenia | |||
Chemotherapy-induced | |||
neuropathy | |||
Pain | |||
AM supplements | 28 (50.0) | Fatigue (Levico D1 or Levico comp D3) | 20 (71.4)* |
Chemotherapy-induced | |||
neuropathy (Aconite nervenoil) | |||
Insomnia (Soleum uleginosum; Avena sativa comp, Hepatodoron) | |||
AM music therapy | 25 (44.6) | Anxiety, restlessness Insomnia | 11 (44)** |
Chemotherapy-induced | 14 (56)*** | ||
neuropathy | |||
Dyspnea | |||
End-of-life care | |||
Pain relief | |||
Nausea, constipation | |||
Fatigue |